A phase II study of ZD6474 (Zactima™), a selective...

A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145

Michael J. Kovacs, Donna E. Reece, Deborah Marcellus, Ralph M. Meyer, Sarah Mathews, Rui-Ping Dong, Elizabeth Eisenhauer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Pages:
7
DOI:
10.1007/s10637-006-9022-7
Date:
November, 2006
File:
PDF, 685 KB
english, 2006
Conversion to is in progress
Conversion to is failed